February 5, 2026 · Form 4 insider transaction
Fox Jennifer A. bought 1,592 shares of Zenas BioPharma, Inc. at $13.35 per share, a transaction worth $21.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 132 days after the transaction.
Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c).